Mode
Text Size
Log in / Sign up

Clinical Trial Search

Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.

Phase
Intervention
Population
Results posted

30 closest matches · ranked by relevance

Phase 2 N=75 Peanut Epicutaneous Phase II Immunotherapy Clinical Trial

Peanut Hypersensitivity · Food Hypersensitivity · Hypersensitivity
Primary: Percentage of Subjects With a Successful Treatment Response — 12.0; 45.8; 48.0 percentage of participants — p=0.005
National Institute of Allergy and Infectious… Results Aug 2016 3.2% serious AE View details

Phase 2 N=14 Omalizumab in the Treatment of Peanut Allergy

Food Allergy · Peanut Allergy
Primary: Number of Participants Who Experienced a Decrease in Pn-BHR Area Under the Curve (AUC) of > 80% Compared With Baseline Values Before Week 8 — 5; 9 Participants
Johns Hopkins University Results Jul 2017 0.0% serious AE View details

Phase 2 N=58 Allergy Immunotherapy for the Reduction of Asthma

Wheezing · Asthma · Allergy
Primary: Asthma Severity as Measured by the Asthma Severity Score (Averaged up to 36 Months) — 21.95; 25.68; 27.72; 27.85 score on a scale — p=0.38
Albert Einstein College of Medicine Results May 2019 26.0% serious AE View details

Phase 2 N=61 Urticaria Facticia Treatment With Omalizumab (UFO)

Symptomatic Dermographism
Primary: Change in Provocation Thresholds From Baseline to Day 70 in Urticaria Factitia Patients After Treatment With Omalizumab Compared to Placebo — -1.8; -2.0; -0.6 wheal…
Charite University, Berlin, Germany Results Jan 2016 4.9% serious AE View details

Phase 2 N=10 Oral Immunotherapy for Peanut Allergy (PMIT)

Food Hypersensitivity
Primary: The Amount of Peanut Protein Ingested Before An Allergic Reaction is Observed During the Double-blind, Placebo Controlled Food Challenge (DBPCFC) After Completing…
University of North Carolina, Chapel Hill Results May 2017 0.0% serious AE View details